Pfizer Inc (PFE)
25.98
+0.60
(+2.34%)
USD |
NYSE |
Apr 19, 16:00
25.94
-0.04
(-0.17%)
After-Hours: 18:00
Pfizer Profit Margin (Quarterly): -23.64% for Dec. 31, 2023
Profit Margin (Quarterly) Chart
Historical Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | -23.64% |
| September 30, 2023 | -18.00% |
| June 30, 2023 | 18.27% |
| March 31, 2023 | 30.32% |
| December 31, 2022 | 20.56% |
| September 30, 2022 | 38.02% |
| June 30, 2022 | 35.71% |
| March 31, 2022 | 30.65% |
| December 31, 2021 | 14.23% |
| September 30, 2021 | 33.89% |
| June 30, 2021 | 29.44% |
| March 31, 2021 | 33.60% |
| December 31, 2020 | 7.40% |
| September 30, 2020 | 14.29% |
| June 30, 2020 | 35.37% |
| March 31, 2020 | 33.27% |
| December 31, 2019 | -31.63% |
| September 30, 2019 | 60.57% |
| June 30, 2019 | 38.04% |
| March 31, 2019 | 29.61% |
| December 31, 2018 | -34.03% |
| September 30, 2018 | 30.94% |
| June 30, 2018 | 28.75% |
| March 31, 2018 | 27.59% |
| December 31, 2017 | 89.57% |
| Date | Value |
|---|---|
| September 30, 2017 | 21.57% |
| June 30, 2017 | 23.83% |
| March 31, 2017 | 24.42% |
| December 31, 2016 | 5.69% |
| September 30, 2016 | 10.39% |
| June 30, 2016 | 15.57% |
| March 31, 2016 | 23.36% |
| December 31, 2015 | -1.22% |
| September 30, 2015 | 17.62% |
| June 30, 2015 | 22.15% |
| March 31, 2015 | 21.87% |
| December 31, 2014 | 9.36% |
| September 30, 2014 | 21.57% |
| June 30, 2014 | 22.80% |
| March 31, 2014 | 20.51% |
| December 31, 2013 | 18.94% |
| September 30, 2013 | 20.49% |
| June 30, 2013 | |
| March 31, 2013 | 22.16% |
| December 31, 2012 | 45.46% |
| September 30, 2012 | 24.77% |
| June 30, 2012 | 23.29% |
| March 31, 2012 | 12.05% |
| December 31, 2011 | 12.08% |
| September 30, 2011 | 22.51% |
Profit Margin Definition
Profit Margin is calculated using Net Income/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into profit. An analyst looking at profit margin might look for a higher profit margin relative to other comparable companies as well as a profit margin that is growing.
Profit Margin (Quarterly) Range, Past 5 Years
-31.63%
Minimum
Dec 2019
60.57%
Maximum
Sep 2019
21.07%
Average
30.32%
Median
Mar 2023
Profit Margin (Quarterly) Benchmarks
| Amgen Inc | 9.36% |
| Gilead Sciences Inc | 20.09% |
| Johnson & Johnson | 25.04% |
| Viking Therapeutics Inc | -- |
| Moderna Inc | 7.71% |
Profit Margin (Quarterly) Related Metrics
| Return on Equity | 2.19% |
| Return on Assets | 1.00% |
| Return on Invested Capital | 1.41% |
| Gross Profit Margin (Quarterly) | 46.92% |
| Operating Margin (Quarterly) | -13.83% |
| Return on Net Operating Assets | 1.48% |